These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11148435)

  • 1. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR.
    Moschetta A; Stolk MF; Rehfeld JF; Portincasa P; Slee PH; Koppeschaar HP; Van Erpecum KJ; Vanberge-Henegouwen GP
    Aliment Pharmacol Ther; 2001 Feb; 15(2):181-5. PubMed ID: 11148435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.
    Turner HE; Lindsell DR; Vadivale A; Thillainayagam AV; Wass JA
    Eur J Endocrinol; 1999 Dec; 141(6):590-4. PubMed ID: 10601961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial gall bladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly.
    Stolk MF; van Erpecum KJ; Koppeschaar HP; de Bruin WI; Jansen JB; Lamers CB; van Berge Henegouwen GP
    Gut; 1993 Jun; 34(6):808-13. PubMed ID: 8314514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly.
    Ewins DL; Javaid A; Coskeran PB; Shah S; Butler J; Deprez PH; Miell J; Calam J; Barrett JJ; Dawson JM
    Q J Med; 1992 Apr; 83(300):295-306. PubMed ID: 1631261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly.
    Catnach SM; Anderson JV; Fairclough PD; Trembath RC; Wilson PA; Parker E; Besser GM; Wass JA
    Gut; 1993 Feb; 34(2):270-3. PubMed ID: 8432484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones.
    Hussaini SH; Pereira SP; Veysey MJ; Kennedy C; Jenkins P; Murphy GM; Wass JA; Dowling RH
    Gut; 1996 May; 38(5):775-83. PubMed ID: 8707128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cisapride on gall bladder emptying, intestinal transit, and serum deoxycholate: a prospective, randomised, double blind, placebo controlled trial.
    Veysey MJ; Malcolm P; Mallet AI; Jenkins PJ; Besser GM; Murphy GM; Dowling RH
    Gut; 2001 Dec; 49(6):828-34. PubMed ID: 11709518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of octreotide on fasting gall bladder emptying, antroduodenal motility, and motilin release in acromegaly.
    Stolk MF; van Erpecum KJ; Koppeschaar HP; Samsom M; Smout AJ; Akkermans LM; Peeters TL; vanBerge-Henegouwen GP
    Gut; 1995 May; 36(5):755-60. PubMed ID: 7797127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Octreotide increases the proportions of arachidonic acid-rich phospholipids in gall-bladder bile.
    Pereira SP; Hussaini SH; Murphy GM; Wass JA; Dowling RH
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1435-43. PubMed ID: 11552916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallstones during octreotide therapy.
    Dowling RH; Hussaini SH; Murphy GM; Wass JA
    Digestion; 1993; 54 Suppl 1():107-20. PubMed ID: 8103009
    [No Abstract]   [Full Text] [Related]  

  • 11. Gallbladder function in acromegalic patients taking long-term octreotide: evidence of rebound hypermotility on cessation of treatment.
    Rhodes M; James RA; Bird M; Clayton B; Kendall-Taylor P; Lennard TW
    Scand J Gastroenterol; 1992; 27(2):115-8. PubMed ID: 1561523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long term octreotide on gall stone formation and gall bladder function.
    Bigg-Wither GW; Ho KK; Grunstein RR; Sullivan CE; Doust BD
    BMJ; 1992 Jun; 304(6842):1611-2. PubMed ID: 1628089
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholelithiasis and acromegaly: therapeutic strategies.
    Montini M; Gianola D; Pagani MD; Pedroncelli A; Caldara R; Gherardi F; Bonelli M; Lancranjan I; Pagani G
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):401-6. PubMed ID: 8187305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipase inhibition by orlistat: effects on gall-bladder kinetics and cholecystokinin release in obesity.
    Mathus-Vliegen EM; Van Ierland-Van Leeuwen ML; Terpstra A
    Aliment Pharmacol Ther; 2004 Mar; 19(5):601-11. PubMed ID: 14987329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallstones during octreotide therapy.
    Dowling RH; Hussaini SH; Murphy GM; Besser GM; Wass JA
    Metabolism; 1992 Sep; 41(9 Suppl 2):22-33. PubMed ID: 1355588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: gall-bladder motor function in diabetes mellitus.
    Pazzi P; Scagliarini R; Gamberini S; Pezzoli A
    Aliment Pharmacol Ther; 2000 May; 14 Suppl 2():62-5. PubMed ID: 10903007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective examination of octreotide-induced gall-bladder changes in acromegaly.
    Eastman RC; Arakaki RF; Shawker T; Schock R; Roach P; Comi RJ; Gorden P
    Clin Endocrinol (Oxf); 1992 Mar; 36(3):265-9. PubMed ID: 1563079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between gall bladder fasting volume and postprandial emptying in patients with gall stones and healthy controls.
    Pauletzki J; Cicala M; Holl J; Sauerbruch T; Schafmayer A; Paumgartner G
    Gut; 1993 Oct; 34(10):1443-7. PubMed ID: 8244118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a European multicentre study with Sandostatin LAR in acromegalic patients. Sandostatin LAR Group.
    Lancranjan I; Atkinson AB
    Pituitary; 1999; 1(2):105-14. PubMed ID: 11081188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of various food ingredients on gall bladder emptying.
    Marciani L; Cox EF; Hoad CL; Totman JJ; Costigan C; Singh G; Shepherd V; Chalkley L; Robinson M; Ison R; Gowland PA; Spiller RC
    Eur J Clin Nutr; 2013 Nov; 67(11):1182-7. PubMed ID: 24045793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.